β-Catenin signaling regulates Foxa2 expression during endometrial hyperplasia formation

Oncogene

Volumn 32, Issue 29, 2013, Pages 3477-3482

  Villacorte, M ^a,b   Suzuki, K ^a,b   Hirasawa, A ^c   Ohkawa, Y ^d   Suyama, M ^e   Maruyama, T ^c   Aoki, D ^c   Ogino, Y ^f   Miyagawa, S ^f   Terabayashi, T ^b   Tomooka, Y ^g   Nakagata, N ^b   Yamada, G ^a,b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f NATIONAL INSTITUTES OF NATURAL SCIENCES   (Japan)

^g TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Cyclin; Endometrial hyperplasia; Foxa2; Uterine gland; Wnt catenin

Indexed keywords

BETA CATENIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BETA CATENIN; ENDOMETRIAL HYPERPLASIA; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84880920923     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.376     Document Type: Article

References (42)

1. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, Kypta RM. Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 2006; 25: 6528-6537. (Pubitemid 44607085)
2. Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-offunction mutations of beta-catenin in mice. Genes Dev 2008; 22: 2308-2341.
3. Kobayashi A, Behringer RR. Developmental genetics of the female reproductive tract in mammals. Nat rev 2003; 4: 969-980. (Pubitemid 37474644)
4. Perantoni AO. Renal development: perspectives on a Wnt-dependent process. Semin Cell Dev Biol 2003; 14: 201-208. (Pubitemid 38160957)
5. Hayashi K, Spencer TE. WNT pathways in the neonatal ovine uterus: potential specification of endometrial gland morphogenesis by SFRP2. Biol Reprod 2006; 74: 721-733.
6. Yu X, Wang Y, DeGraff DJ, Wills ML, Matusik RJ. Wnt/beta-catenin activation promotes prostate tumor progression in a mouse model. Oncogene 2011; 30: 1868-1879.
7. Nei H, Saito T, Yamasaki H, Mizumoto H, Ito E, Kudo R. Nuclear localization of betacatenin in normal and carcinogenic endometrium. Mol Carcinog 1999; 25: 207-218. (Pubitemid 29319286)
8. Jeong JW, Lee HS, Franco HL, Broaddus RR, Taketo MM, Tsai SY et al. beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene 2009; 28: 31-40.
9. Scholten AN, Creutzberg CL, van den Broek LJ, Noordijk EM, Smit VT. Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460-465. (Pubitemid 37408267)
10. Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, Armstrong K et al. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor. Cancer Res 2004; 64: 7918-7926. (Pubitemid 39446925)
11. Sasaki H, Hogan BL. Enhancer analysis of the mouse HNF-3 beta gene: regulatory elements for node/notochord and floor plate are independent and consist of multiple sub-elements. Genes Cells 1996; 1: 59-72. (Pubitemid 126673107)
12. Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 2002; 9: 279-289. (Pubitemid 34195554)
13. Kaestner KH. The FoxA factors in organogenesis and differentiation. Curr Opin Genet Dev 2010; 20: 527-532.
14. Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene 2006; 25: 1391-1399. (Pubitemid 43336467)
15. Ojalvo LS, Whittaker CA, Condeelis JS, Pollard JW. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 2010; 184: 702-712.
16. Suzuki K, Yamaguchi Y, Villacorte M, Mihara K, Akiyama M, Shimizu H et al. Embryonic hair follicle fate change by augmented beta-catenin through Shh and Bmp signaling. Development 2009; 136: 367-372.
17. Tarutani M, Itami S, Okabe M, Ikawa M, Tezuka T, Yoshikawa K et al. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci USA 1997; 94: 7400-7405. (Pubitemid 27345327)
18. Cunha GR. Epithelial-stromal interactions in development of the urogenital tract. Int Rev Cytol 1976; 47: 137-194.
19. Cunha GR. Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the Mullerian ducts and urogenital sinus during development of the uterus and vagina in mice. J Exp Zool 1976; 196: 361-370.
20. Kurita T, Cooke PS, Cunha GR. Epithelial-stromal tissue interaction in paramesonephric (Mullerian) epithelial differentiation. Dev Biol 2001; 240: 194-211. (Pubitemid 33143820)
21. Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 2001; 32: 569-577. (Pubitemid 32601237)
22. Berchuck A, Boyd J. Molecular basis of endometrial cancer. Cancer 1995; 76: 2034-2040.
23. Wang Y, Hanifi-Moghaddam P, Hanekamp EE, Kloosterboer HJ, Franken P, Veldscholte J et al. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer. Clin Cancer Res 2009; 15: 5784-5793.
24. Huang WW, Yin Y, Bi Q, Chiang TC, Garner N, Vuoristo J et al. Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol endocrinol 2005; 19: 669-682. (Pubitemid 40349439)
25. Armaiz-Pena GN, Mangala LS, Spannuth WA, Lin YG, Jennings NB, Nick AM et al. Estrous cycle modulates ovarian carcinoma growth. Clin Cancer Res 2009; 15: 2971-2978.
26. Daikoku T, Jackson L, Besnard V, Whitsett J, Ellenson LH, Dey SK. Cell-specific conditional deletion of Pten in the uterus results in differential phenotypes. Gynecol Oncol 2011; 122: 424-429.
27. Daikoku T, Dey SK. Two faces of PTEN. Nat Med 2008; 14: 1192-1193.
28. Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP et al. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 2008; 68: 5619-5627.
29. Fyles A, Wood G, Li M, Manoukian AS, Gowing K, Khokha R et al. Neither ovariectomy nor progestin treatment prevents endometrial neoplasia in pten+/- mice. Gynecol Oncol 2008; 108: 395-401. (Pubitemid 351181444)
30. Jeong JW, Kwak I, Lee KY, Kim TH, Large MJ, Stewart CL et al. Foxa2 is essential for mouse endometrial gland development and fertility. Biol Reprod 2011; 83: 396-403.
31. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005; 15: 1034-1050. (Pubitemid 41126859)
32. Giannini A, Mazor M, Orme M, Vivanco M, Waxman J, Kypta R. Nuclear export of alpha-catenin: overlap between nuclear export signal sequences and the betacatenin binding site. Exp Cell Res 2004; 295: 150-160. (Pubitemid 38407353)
33. Mo B, Vendrov AE, Palomino WA, DuPont BR, Apparao KB, Lessey BA. ECC-1 cells: a well-differentiated steroid-responsive endometrial cell line with characteristics of luminal epithelium. Biol Reprod 2006; 75: 387-394. (Pubitemid 44268073)
34. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS et al. The UCSC Genome browser database: update 2011. Nucleic acids res 2011; 39: D876-D882.
35. Yue X, Lan F, Yang W, Yang Y, Han L, Zhang A et al. Interruption of beta-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. Brain Res 2010; 1366: 27-37.
36. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M. A cell-typespecific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 2006; 20: 2513-2526. (Pubitemid 44396837)
37. Hanazono M, Tomisawa H, Tomooka Y, Hirabayashi K, Aizawa S. Establishment of uterine cell lines from p53-deficient mice. In Vitro Cell Dev Biol Anim 1997; 33: 668-671.
38. Guzzo F, Bellone S, Buza N, Hui P, Carrara L, Varughese J et al. HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas. Int J Gynecol Pathol 2012; 31: 211-221.
39. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM. Mining for regulatory programs in the cancer transcriptome. Nat Genet 2005; 37: 579-583. (Pubitemid 40770410)
40. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W et al. Nuclear PKM2 regulates betacatenin transactivation upon EGFR activation. Nature 2011; 480: 118-122.
41. Silverberg SG. Molecular diagnosis and prognosis in gynecologic oncology. Arch Pathol Lab Med 1999; 123: 1035-1040.
42. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-642. (Pubitemid 26268958)